| Original language | English |
|---|---|
| Article number | 14 |
| Journal | Clinical Hypertension |
| Volume | 26 |
| Publication status | Published - 2020 |
The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms.
Research output: Contribution to journal › Article › peer-review